Bharat Parenterals Ltd
₹1262
(4.30%)
Thu, 14 May 2026, 02:50 pm
Health Technology
Pharmaceuticals: Major
24.5KBharat Parenterals Share Price Live Chart
1 Day
(4.30%)
No Result Found
Summary
Market Cap
854.67
Net Profit
-43.68
P/B
2.06
Sector P/E
34.42
P/E
0
EV/EBITDA
56.08
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.95
ROCE (Industry)
16.47
RONW (Industry)
14.44
ROE
-16.55
ROCE
-4.76
Debt/Equity
0.64
EPS (TTM)
0
Dividend Yield
0.08
Book Value
480.27
Interest Cover
-1.62
Analysis
all
- Bharat Parenterals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Bharat Parenterals is profitable, therefore cash runway is not a concern.
- Bharat Parenterals is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (1147.9%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 74.3x debt.
- Unable to evaluate Bharat Parenterals's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Bharat Parenterals's dividend against the top 25% market benchmark as the company has not reported any payouts.
- High level of physical assets or inventory.
- Bharat's remuneration is higher than average for companies of similar size in India.
- Bharat Parenterals is not covered by any analysts.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 67.17 | 67.19 | 67.19 | 67.19 | 67.20 |
| FII | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 |
| DII | 1.06 | 0.54 | 0.54 | 0.54 | 0.54 |
| Public | 31.66 | 32.15 | 32.15 | 32.16 | 32.15 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1883.83 | 1507.33 | 1360.17 | 1130.83 | 983.67 | 754.33 | 377.83 |
| Fibonacci | 1507.33 | 1363.51 | 1274.66 | 1130.83 | 987.01 | 898.16 | 754.33 |
| Camarilla | 1316.54 | 1282.03 | 1247.51 | 1130.83 | 1178.49 | 1143.97 | 1109.46 |
Pivots Level: Classic
R3
+753
1883.83
R2
+376.50
1507.33
R1
+229.33
1360.17
S1
-147.17
983.67
S2
-376.50
754.33
S3
-753
377.83
Moving Average
Period
Value
10-EMA
1231.66
20-EMA
1214.66
30-EMA
1193.75
50-EMA
1165.52
100-EMA
1151.37
200-EMA
1174.71
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 30 Jan 2026 | board-meetings | Quarterly Results | |
| 04 Sept 2025 | agm | ||
| 19 Aug 2025 | dividend | Final Dividend - Rs. - 1 | 19 Sept 2025 |
| 12 May 2025 | dividend | ₹1.00 Dividend /Share | 19 Sept 2025 |
| 10 Jun 2024 | agm | ||
| 25 May 2024 | dividend | Final Dividend - Rs. - 1 | 25 Jun 2024 |
| 22 May 2024 | dividend | ₹1.00 Dividend /Share | 25 Jun 2024 |
| 29 Apr 2024 | egm | ||
| 01 Sept 2023 | agm | ||
| 25 Aug 2023 | dividend | Final Dividend - Rs. - 0.75 | 25 Sept 2023 |
Peer Comparison
Bharat Parenterals Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Cipla Ltd
Divis Laboratories Ltd
Bharat Parenterals Ltd About
Bharat Parenterals as a pharmaceutical company. The Company develops anti-retroviral drugs in the form of tablets, capsules, oral liquids, eye drops, lotion, creams, and injections for the treatment of various diseases. Bharat Parenterals serves clients in India.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1992
Headquarters
CEO
Bharat Kumar R Desai
Employees
Contact
Website
http://www.bplindia.in
info@bplindia.in
Phone
91-2667-251679
Location
Survey No 144 & 146 Haripura, Jarod Samlaya Road Tal Savli, Vadodara, Gujarat, 391520
Bharat Parenterals Ltd Company History
| Year | History |
|---|---|
| 1992 |
|
| 2021 |
|
| 2025 |
|
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800